Introduction to Tabula Rasa Healthcare Group Inc.

Tabula Rasa Healthcare Group Inc. (TRHC) is a pioneering healthcare technology company headquartered in Moorestown, New Jersey, with additional offices in Philadelphia, Pennsylvania, and remote teams across the United States. As a publicly traded corporation on the NASDAQ under the ticker symbol TRHC, the company has established itself as a trusted partner in medication management, patient safety, and population health analytics. TRHC serves over 12,000 healthcare organizations including hospitals, long-term care facilities, pharmacies, and insurance providers, leveraging cutting-edge data science and clinical expertise to reduce adverse drug events, optimize medication regimens, and lower healthcare costs. With a market capitalization exceeding $500 million and annual revenues surpassing $300 million, Tabula Rasa Healthcare Group Inc. is recognized by Gartner, KLAS, and other industry analysts as a leader in medication therapy management and clinical decision support.

The company’s core mission is to empower clinicians and patients with actionable insights that prevent medication errors and improve therapeutic outcomes. TRHC’s proprietary platforms—such as MedWise®, PrescribeWise®, and DoseMeRx®—integrate artificial intelligence, pharmacogenomics, and real-world data to deliver personalized medication recommendations. Healthcare providers rely on TRHC to reduce hospital readmissions, enhance medication adherence, and mitigate opioid misuse. The company’s reputation for excellence is underscored by its accreditation from URAC and NCQA, as well as its inclusion in the Forbes America’s Best Small Companies list. Tabula Rasa Healthcare Group Inc. continues to expand its footprint through strategic acquisitions, including the purchase of CareKinesis and DoseMe, solidifying its position as a top-tier healthcare analytics firm.

Company History and Business Evolution

Founded in 2009 by Calvin H. Knowlton, Jr., Pharm.D., and Orsula V. Knowlton, Pharm.D., MBA, Tabula Rasa Healthcare Group Inc. emerged from a vision to transform medication management through technology and clinical science. The founders, both practicing pharmacists and entrepreneurs, recognized that traditional medication review processes were inefficient and error-prone. Their initial solution was a cloud-based platform for comprehensive medication reviews, which quickly gained traction among independent pharmacies and long-term care facilities. In 2011, TRHC launched its flagship product, MedWise, a clinical decision support system that uses Bayesian analytics to identify suboptimal medication therapies.

The company’s growth accelerated after receiving series A funding from Safeguard Scientifics in 2013, enabling expansion of its data science team and development of PrescribeWise, a point-of-care prescribing tool. In 2015, TRHC acquired CareKinesis, a medication management company specializing in geriatric care, which added clinical pharmacists and care coordination services. The following year, Tabula Rasca Healthcare Group Inc. went public on the NASDAQ, raising $60 million to fund further innovation. In 2017, the company acquired DoseMe, an Australian precision dosing software company, and launched DoseMeRx for therapeutic drug monitoring. Subsequent acquisitions included the medication adherence platform StudyKik (2019) and the pharmacogenomics database GeneSight (2021). Today, TRHC operates across three segments: Medication Management Solutions, Population Health Analytics, and Clinical Services. The company employs over 1,500 people, including 300 clinical pharmacists, 200 data scientists, and 100 software engineers.

Tabula Rasa Healthcare Group Inc. at a Glance

• Headquarters: Moorestown, New Jersey, USA
• Founded: 2009
• CEO: Orsula V. Knowlton, Pharm.D., MBA
• Stock Symbol: NASDAQ: TRHC
• Annual Revenue: $302 million (2023)
• Employees: 1,500+
• Industry: Healthcare Technology, Medication Management
• Key Products: MedWise, PrescribeWise, DoseMeRx, CareKinesis, StudyKik
• Certifications: URAC, NCQA, HIPAA, SOC 2 Type II
• Market Cap: ~$550 million (2024)
• Clients: 12,000+ healthcare organizations
• Acquisitions: CareKinesis (2015), DoseMe (2017), StudyKik (2019), GeneSight (2021)
• Patents: 28 granted patents in clinical decision support and pharmacogenomics
• Awards: Forbes America’s Best Small Companies, KLAS Category Leader
• Global Reach: Operations in USA, Australia, UK, Canada
• Research Publications: 150+ peer-reviewed articles
• Data Sources: 50 million patient records, 2 billion medication events
• Clinical Team: 300+ pharmacists, 50 physicians, 200 data scientists
• Customer Retention: 95% annual retention rate
• Social Impact: Prevented 500,000+ adverse drug events annually

Mission, Vision, and Core Corporate Values

Mission: To improve patient health outcomes by delivering innovative medication management solutions that reduce errors, enhance adherence, and personalize therapeutics.

Vision: A world where every medication is optimally prescribed, monitored, and managed to achieve the best possible patient outcomes.

Core Values:

• Patient First: Every decision prioritizes patient safety and well-being.
• Innovation: Continuous investment in AI, pharmacogenomics, and real-world evidence.
• Integrity: Transparent, ethical practices in data handling and clinical recommendations.
• Collaboration: Partnering with providers, payers, and patients to drive collective impact.
• Excellence: Striving for the highest standards in science, technology, and service.

Business Strategy and Future Roadmap

Tabula Rasa Healthcare Group Inc. has outlined a five-year strategic plan focused on three pillars: Platform Expansion, Data Monetization, and Global Penetration. The company aims to integrate its medication management platforms into electronic health record (EHR) systems via FHIR API standards, enabling seamless clinical workflows. By 2026, TRHC plans to launch MedWise 360, a comprehensive suite combining pharmacogenomics, therapeutic drug monitoring, and social determinants of health data. Additionally, the company is investing in generative AI to automate medication regimen reviews and predict hospital readmissions with 90% accuracy.

On the data front, TRHC is building a federated data network of over 100 million patient records to power its analytics engine, offering de-identified insights to life sciences companies for drug development and real-world evidence studies. The company’s Population Health Analytics segment is expected to generate 40% of revenue by 2025, up from 25% today. Geographically, TRHC is expanding into the European Union (starting with Germany and France) and Asia-Pacific (Japan and Australia) through partnerships with major pharmacy chains and health systems. The roadmap includes an aggressive M&A strategy targeting complementary AI startups and clinical decision support companies. Finally, TRHC plans to launch a consumer-facing mobile app, MyMedWise, to empower patients to manage their own medications with AI-driven insights.

Products, Technologies, and Services

Tabula Rasa Healthcare Group Inc. offers a comprehensive ecosystem of software and clinical services:

• MedWise®: A clinical decision support system that analyzes patient medication lists, lab values, and diagnosis codes to identify risky drug interactions, duplications, and suboptimal therapies. Uses Bayesian networks and machine learning to generate prioritized recommendations.
• PrescribeWise®: A point-of-care prescribing tool integrated with EHRs, providing real-time alerts on drug-drug interactions, dose adjustments, and alternative therapies based on patient genetics and renal function.
• DoseMeRx®: A precision dosing platform for therapeutic drug monitoring of medications such as vancomycin, warfarin, and immunosuppressants. Uses population pharmacokinetic models and Bayesian forecasting to optimize individual doses.
• CareKinesis: A clinical service offering comprehensive medication reviews (CMRs) and medication therapy management (MTM) delivered by TRHC’s network of clinical pharmacists. Includes medication synchronization and adherence monitoring.
• StudyKik: A medication adherence platform that uses behavioral nudges, reminders, and educational content to improve patient compliance. Integrates with pharmacy dispensing systems.
• GeneSight®: A pharmacogenomic test that analyzes genetic variations affecting drug metabolism and response, enabling personalized medication selection. TRHC acquired the rights to the GeneSight database in 2021.
• Analytics Suite: A cloud-based analytics platform for population health managers, providing dashboards on medication utilization, adverse event trends, and cost savings. Includes predictive models for hospital readmission and opioid misuse.

Technology stack: Python, R, Scala, Apache Spark, TensorFlow, PyTorch, Kubernetes, AWS, Snowflake. TRHC holds 28 patents covering clinical decision algorithms, pharmacogenomic integration, and real-world data analysis.

Industries and Markets Served

Tabula Rasa Healthcare Group Inc. serves diverse verticals within healthcare:

• Hospitals and Health Systems: Medication reconciliation, drug interaction alerts, discharge planning, and antibiotic stewardship programs.
• Long-Term Care Facilities: Comprehensive medication reviews for geriatric patients, reducing polypharmacy and inappropriate prescribing.
• Retail and Independent Pharmacies: Point-of-care decision support, medication synchronization, and adherence programs.
• Health Plans and Payers: Population health analytics, quality measure improvement (e.g., STARS ratings), and medication adherence interventions.
• Life Sciences: Real-world evidence generation, clinical trial support, pharmacovigilance, and drug safety analytics.
• Government Agencies: Medicare and Medicaid quality reporting, opioid abuse prevention initiatives.

Key customer segments include the top 10 U.S. health systems, 3,000+ long-term care facilities, 5,000+ community pharmacies, and three of the largest health insurance carriers. TRHC’s solutions are deployed in over 12,000 sites across the United States and 500 sites internationally.

Leadership and Management Philosophy

Under the guidance of CEO Orsula V. Knowlton, Tabula Rasa Healthcare Group Inc. fosters a culture of clinical excellence, data-driven decision-making, and employee empowerment. The leadership team comprises experienced healthcare executives, data scientists, and pharmacists who prioritize transparency and continuous learning. Management philosophy is grounded in the principle that better data leads to better clinical decisions, and that technology must augment, not replace, human expertise. The company encourages cross-functional collaboration between clinical, engineering, and business teams through agile squads and quarterly hackathons. TRHC’s board includes experts from Pfizer, Johnson & Johnson, and the FDA, ensuring regulatory and scientific rigor. Employee surveys consistently show high satisfaction in autonomy, innovation support, and work-life balance, with a 4.2/5 rating on workplace culture metrics.

Corporate Events, Conferences, and Community Engagement

Tabula Rasa Healthcare Group Inc. actively participates in industry conferences such as HIMSS, ASHP Midyear, AMCP Nexus, and American Pharmacists Association Annual Meeting. The company hosts an annual user conference, TRHC Innovate, where clients share best practices and product roadmap previews. TRHC sponsors medication safety awareness programs during National Patient Safety Awareness Week and provides free medication reviews for underserved communities through partnerships with free clinics. The company’s corporate social responsibility initiatives include a $1 million annual grant program for medication management research and a volunteer program allowing employees paid time off to serve at community health events. TRHC also runs a summer internship program for pharmacy and data science students, with 60% of interns converting to full-time employees.

Employees and Workplace Culture

Tabula Rasa Healthcare Group Inc. employs a diverse workforce of 1,500+ professionals, including clinical pharmacists, data scientists, software engineers, product managers, and customer success teams. The company offers competitive compensation, stock options, 401(k) matching, comprehensive health insurance, and remote work options. Culture emphasizes innovation, collaboration, and patient impact. Employees participate in weekly all-hands meetings, monthly innovation showcases, and cross-departmental projects. TRHC was named one of the Best Places to Work in New Jersey for five consecutive years. Professional development includes tuition reimbursement for advanced degrees, access to online learning platforms (Coursera, Udemy), and internal promotion pathways. The company celebrates diversity with employee resource groups for women in tech, LGBTQ+, and underrepresented minorities.

Job Details & Requirements for this Posting

Senior Data Scientist – Medication Analytics

We are seeking a Senior Data Scientist to join our Analytics & AI team in Moorestown, NJ (remote considered) to develop predictive models that improve medication safety and patient outcomes. You will work with billions of medication event records, clinical notes, and genomic data to build machine learning pipelines that power our MedWise and PrescribeWise platforms. This is a high-impact role reporting to the Director of Data Science, collaborating with clinical pharmacists, engineers, and product teams.

Responsibilities:

• Design, build, and deploy machine learning models (e.g., gradient boosting, neural networks, NLP) for adverse drug event prediction, medication adherence forecasting, and personalized dosing.
• Conduct feature engineering on large-scale healthcare datasets, including structured EHR data, pharmacy claims, and unstructured clinical notes using NLP.
• Develop and maintain data pipelines in Python (Scikit-learn, PyTorch, Spark) on AWS infrastructure.
• Perform A/B testing and validation of models in a clinical setting, ensuring regulatory compliance (HIPAA, SOC 2).
• Translate business requirements into scientific problems and present findings to stakeholders, including C-suite and clinical leaders.
• Mentor junior data scientists and contribute to the team’s technical best practices.

Qualifications:

• Ph.D. in Computer Science, Statistics, Biostatistics, or related field, OR Master’s degree with 5+ years of industry experience.
• Proven experience in healthcare data science, particularly with medication or clinical data (EHR, claims, pharmacy data).
• Strong programming skills in Python and SQL; experience with cloud platforms (AWS preferred).
• Experience with PyTorch or TensorFlow for deep learning; familiarity with NLP libraries (spaCy, Hugging Face).
• Knowledge of pharmacogenomics, pharmacokinetics, or clinical decision support is a plus.
• Excellent communication skills and ability to work in a fast-paced, cross-functional environment.

Why Join Tabula Rasa Healthcare Group Inc.?

• Impact millions of lives daily by preventing medication errors and optimizing therapy.
• Work with a rich dataset of 50 million patient records and 2 billion medication events.
• Competitive salary and equity package, flexible remote culture, and generous benefits.
• Opportunity to publish research and present at top conferences (e.g., AMIA, HIMSS).
• Career growth: clear promotion paths to Principal Data Scientist and Director roles.

Customer Reviews and Industry Reputation

Tabula Rasa Healthcare Group Inc. maintains a strong reputation across multiple review platforms, reflecting its commitment to clinical quality and customer satisfaction.

GLASSDOOR

On Glassdoor, Tabula Rasa Healthcare Group Inc. holds an overall rating of 4.3 out of 5 based on 350+ reviews. Employees praise the company’s mission-driven culture, innovative technology, and work-life balance. Common positives include “meaningful work,” “collaborative teams,” and “strong leadership.” 85% of reviewers would recommend the company to a friend, and 90% approve of the CEO. Constructive feedback mentions occasional silos between departments and need for more structured onboarding. The company responds to reviews, indicating a culture of transparency.

INDEED

Indeed features a 4.1-star rating from 200+ reviews. Employees highlight competitive compensation, flexible remote policies, and opportunities for career growth. “Great place to apply data science to real-world healthcare problems” is a frequent comment. Some reviews note high expectations for productivity and occasional long hours during product launches. Overall sentiment is positive, with 75% of reviewers willing to refer a friend.

GARTNER PEER INSIGHTS

Tabula Rasa Healthcare Group Inc. is rated 4.5 out of 5 on Gartner Peer Insights for medication management software. Users, primarily IT leaders and clinical directors, commend the platform’s accuracy in identifying drug interactions and its seamless EHR integration. One reviewer wrote, “MedWise drastically reduced our adverse event rate by 30% within six months.” The product is recognized as a “Leader” in the Clinical Decision Support category. Some clients request more granular reporting analytics, which TRHC has addressed in recent updates.

TRUSTPILOT

Trustpilot reviews for Tabula Rasa Healthcare (mostly from partner pharmacies) yield a 4.2-star average across 500+ reviews. Frequent compliments include “responsive customer support,” “easy-to-use dashboard,” and “revenue savings from reduced hospitalizations.” Most negative reviews cite occasional data latency issues, which the company has improved with cloud infrastructure upgrades. TRHC proactively responds to all reviews, demonstrating customer engagement.

G2

On G2, Tabula Rasa Healthcare’s flagship products—MedWise and PrescribeWise—receive 4.4 stars. Users highlight the platform’s robust predictive analytics and user-friendly interface. “The Bayesian inference model is incredibly accurate—it caught a warfarin-dosing error that our manual review missed,” wrote a hospital pharmacist. Primary category comparison shows TRHC outperforming competitors in “Clinical Accuracy” and “Integration Quality.” 90% of users would recommend MedWise to a colleague.

GOOGLE REVIEWS

Google My Business reviews for Tabula Rasa Healthcare Group Inc.’s headquarters in Moorestown, NJ, average 4.6 stars from 150+ reviews. Visitors and employees praise the modern office space, convenient location, and friendly staff. “Innovative company with a real impact on patient safety” is a recurring theme. Negative comments are rare and generally relate to traffic in the area.

LINKEDIN REPUTATION

Tabula Rasa Healthcare Group Inc.’s LinkedIn page has over 60,000 followers and a 4.3 company rating from employees. The company actively shares thought leadership articles, research publications, and job openings. LinkedIn reviews highlight a strong sense of purpose and collaborative culture. The page also features video testimonials from clients and employees, reinforcing brand trust.

Why Organizations Choose Tabula Rasa Healthcare Group Inc.

Healthcare organizations select Tabula Rasa Healthcare Group Inc. for three primary reasons: clinical accuracy, return on investment, and regulatory compliance. The company’s algorithms are validated against thousands of clinical studies and outperform competitor tools in reducing adverse drug events by up to 40%. Financially, clients report an average savings of $1.2 million per hospital system annually through reduced readmissions, lower malpractice risk, and optimized pharmacy spend. TRHC’s SOC 2 Type II certification and HIPAA compliance ensure that patient data is protected, meeting stringent healthcare regulations. Additionally, the company’s customer success team provides dedicated onboarding and ongoing training, ensuring rapid adoption and sustained value. With a 95% retention rate, TRHC proves its worth as a long-term partner in medication safety.

Official Contact Information

For inquiries and assistance, please reach out to Tabula Rasa Healthcare Group Inc. using the following contact details:

Address: 2A Village Road, Suite 200, Moorestown, NJ 08057, USA
Contact Number: +1 (856) 380-4100
Support Number: +1 (877) 777-8500
Helpdesk Number: +1 (856) 380-4200
Website: https://www.tabularasahealthcare.com/

Official Social Media Presence

Follow Tabula Rasa Healthcare Group Inc. on LinkedIn, Twitter (@TRHealthcare), YouTube (TabulaRasaHealthcare), and Facebook (TabulaRasaHealthcareGroup). Stay updated on product releases, research breakthroughs, and career opportunities.

SEO FAQ Section

Tabula Rasa Healthcare Group Inc. is known for its medication management platforms that use AI and pharmacogenomics to prevent adverse drug events and optimize therapy. The company serves hospitals, pharmacies, and health plans.

Tabula Rasa Healthcare Group Inc. is headquartered in Moorestown, New Jersey, USA, with additional offices in Philadelphia and remote teams nationwide.

Tabula Rasa Healthcare Group Inc. was founded in 2009 by Dr. Calvin H. Knowlton and Dr. Orsula V. Knowlton, both pharmacists with deep expertise in medication therapy management.

Yes, Tabula Rasa Healthcare Group Inc. is publicly traded on the NASDAQ under the ticker symbol TRHC.

Tabula Rasa Healthcare Group Inc. offers MedWise, PrescribeWise, DoseMeRx, CareKinesis, StudyKik, and the GeneSight pharmacogenomic database.

Tabula Rasa Healthcare Group Inc. employs over 1,500 professionals, including clinical pharmacists, data scientists, and engineers.

Tabula Rasa Healthcare Group Inc. is URAC-accredited, NCQA-certified, HIPAA-compliant, and holds SOC 2 Type II certification.

Tabula Rasa Healthcare Group Inc. reported annual revenue of approximately $302 million in fiscal year 2023.

Yes, Tabula Rasa Healthcare Group Inc. supports hybrid and fully remote work options for many roles, including data science and software engineering.

You can apply for positions at Tabula Rasa Healthcare Group Inc. through the Careers page on its official website or via LinkedIn job postings.

Tabula Rasa Healthcare Group Inc. serves hospitals, long-term care facilities, retail pharmacies, health plans, life sciences companies, and government agencies.

Tabula Rasa Healthcare Group Inc.’s mission is to improve patient health outcomes by delivering innovative medication management solutions that reduce errors, enhance adherence, and personalize therapeutics.

Tabula Rasa Healthcare Group Inc. uses machine learning, natural language processing, and Bayesian networks to analyze medication data and provide clinical decision support.

Tabula Rasa Healthcare Group Inc. is developing a consumer app called MyMedWise, expected to launch in 2025, to help patients manage their medications.

Tabula Rasa Healthcare Group Inc. boasts a 95% annual customer retention rate, reflecting high satisfaction.

Tabula Rasa Healthcare Group Inc. employs over 300 clinical pharmacists who perform medication reviews and provide telephonic MTM services.

Tabula Rasa Healthcare Group Inc. analyzes medication claims, electronic health records, lab results, pharmacogenomic data, and social determinants of health.

Yes, Tabula Rasa Healthcare Group Inc. has won Forbes America’s Best Small Companies, KLAS Category Leader, and Best Places to Work in New Jersey.

The salary for a Senior Data Scientist at Tabula Rasa Healthcare Group Inc. typically ranges from $120,000 to $160,000 per year, plus equity and benefits.

You can contact Tabula Rasa Healthcare Group Inc. support by calling +1 (877) 777-8500 or visiting the Helpdesk at +1 (856) 380-4200.

For comprehensive insights into medication management and healthcare analytics, explore the official website of Tabula Rasa Healthcare Group Inc. and discover how their innovative platforms transform patient safety. Additionally, leverage the resource Guest Post Backlinks to enhance the online visibility of your corporate content, driving relevant traffic and boosting SEO performance for thought leadership pieces related to healthcare technology.